Clinical Trials Logo

Neurogenic Thoracic Tumors clinical trials

View clinical trials related to Neurogenic Thoracic Tumors.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04554173 Completed - Clinical trials for Neurogenic Thoracic Tumors

An Appraisal of Minimal Invasive Surgery for Thoracic Neurogenic Tumour

DIUOP
Start date: April 24, 2020
Phase:
Study type: Observational

Mediastinal neurogenic tumors are relatively rare in children. Surgical resection is essential. Minimal invasive surgery is more and more used in pediatric population, but his evaluation for resection of thoracic neurogenic tumors is little studied. Thoracotomy has specific long terms post operative complications. When compared to thoracotomy, thoracoscopy shows less operative blood loss, shorter duration of chest tube ans length of stay. Recently, the indications of thoracoscopic approach have been assessed according to the presence or absence of image-defined risk factors (IDRF) at diagnosis and after preoperative chemotherapy in a monocentric retrospective study. The investigators aimed to conduct a multicentric retrospective study to assess the role of thoracoscopy in neurogenic thoracic tumours according to the presence or absence of IDRF at diagnosis, the surgical complications and outcome.